Purdue's Sleep Aid Patents Are Obvious, Judge Rules

March 30, 2015

Law360, New York (March 30, 2015, 3:01 PM ET) -- A New Jersey federal judge on Friday found that Purdue Pharmaceutical Products LP’s three patents for sleep aid Intermezzo are invalid for obviousness, granting a win to Actavis Elizabeth LLC, Novel Laboratories Inc. and others whom Purdue sued over plans to market their own generic versions of the drug.

All Content © 2003‐2015, Portfolio Media, Inc.

Jake M. Holdreith

Partner

Member of Executive Board

Related Publications

Third Quarter
ANDA Approvals
GENERICally Speaking Fall 2021
Third Quarter
ANDA Litigation Settlements
GENERICally Speaking Fall 2021
Third Quarter
Generic Launches
GENERICally Speaking Fall 2021
Third Quarter
New ANDA Cases
GENERICally Speaking Fall 2021
September 1, 2021
Belcher Pharms., LLC v. Hospira, Inc.
GENERICally Speaking Fall 2021
Back to Top